Why Companies Are Bringing Contract Manufacturing Back to the U.S?
Global supply chains are facing unexpected disruptions, and rising tariffs and import costs are making U.S. in-country manufacturing more lucrative. By bringing manufacturing back to America, brands gain stronger control, greater speed, stronger IP protection, regulatory alignment, and supply-chain resilience. So, what are the key categories influencing this massive shift?
Scope in Adhesive Manufacturing
Adhesive manufacturing requires tight process control, which requires skilled, U.S.-based operations and closer proximity. Domestic production reduces the risk of offshore quality variation, logistics delays, or supply-chain disruptions when sourcing adhesive materials or converting films. For medical and adhesive original equipment manufacturers (OEMs), working closely with U.S. adhesive manufacturers improves collaboration on new products and innovation for adhesive device development.
Scope in Liquid Filling Manufacturing
With a vertically integrated facility that handles formulation, compounding, filling, packaging and stability testing, brands benefit from faster turnaround times and consistent quality. This setup reduces risks of foreign regulatory non-compliance, long shipping timelines, and tariff-related delays.
For brands seeking agility, partnering with a company like Strukmyer, a U.S.-based contract liquid-filling company, becomes a major competitive advantage. We offer high-performance liquid-filling capabilities (tube, powder, vial, bottle, form-fill) for pharmaceuticals, medical devices, and cosmetics.
Speed that scales: Whether it’s a 1-oz bottle or a 1-gallon container, Strukmyer can fill up to 60 units every minute, and handle 50 tubes per minute for 1-3 ml formats.
5 Reasons U.S. Contract Manufacturing Is the Smarter Choice in 2025
Global supply chain disruptions, rising import costs, and increasing demand for quality control are pushing companies to rethink where and how they manufacture. Here are five powerful reasons why bringing your contract manufacturing back to America makes sense.
1. Tariffs & Rising Import Costs
The U.S. has imposed sweeping manufacturer tariffs on imported goods, including medical devices and healthcare components. Some tariffs are as high as 25%, and general duty burdens continue to rise. Even a 1% increase in duties on imported components can significantly raise finished-goods costs, especially across medical and pharmaceutical supply chains!By shifting production to the U.S., brands avoid duty exposure, reduce landed-cost unpredictability, and remove the risk of future tariff escalation. Domestic contract manufacturing enables cost predictability and supply-chain resilience amid global trade friction.
2. Intellectual Property & Formula Protection
Sensitive formulas, proprietary adhesive chemistries, and specialised liquid-fill formulations all carry elevated IP risks when managed overseas. Partnering with an American facility ensures stronger oversight, confidentiality, security, and rapid change control.
Domestic manufacturing reduces the risk of unauthorised subcontracting and foreign diversion issues. For OEMs, developing IP-heavy products such as medical adhesives, wound-care dressings, or custom formulations, “Made in USA” backed by integrated adhesive manufacturers adds trust, quality, and brand value.
3. FDA Scrutiny on Foreign Facilities
Foreign manufacturers often face thorough regulatory scrutiny from the FDA, including import inspections and product holds. Supply chain driven by trade amplifies regulatory risk.
Working with a U.S.-based, FDA-registered, ISO 13485-certified contract manufacturing partner simplifies compliance and oversight. Domestic production ensures easier audits, smoother change controls, and higher transparency.
4. Transparency in Change Control
Change control is far easier when your contract manufacturer is local, integrated, and responsive. They enable tighter coordination across functions, from concept to completion.
This transparency is essential for medical, adhesive, and OTC manufacturers who must document changes and report to regulators. Domestic manufacturing improves traceability, accelerates approvals, and eliminates delays caused by overseas coordination challenges.
5. Faster Communication & Shorter Lead Times
Let’s face it – U.S.-based operations cut shipping times, customs delays, and overseas bottlenecks, resulting in faster prototyping, scale-up, and market response.
Brands developing new adhesive devices or specialised liquid-fill products benefit from shorter lead times, faster iterations, and reduced inventory risk. With global uncertainty on the rise, partnering with a U.S. contract liquid-filling company brings more than cost savings – expect speed, flexibility, and operational confidence.
Conclusion
The convergence of tariff pressure, IP and regulatory complexity, supply-chain unpredictability, and the growing need for speed means U.S. contract manufacturing is no longer optional – it’s a strategic priority. Strukmyer is a true-blue American, vertically integrated, end-to-end contract manufacturing partner built to support brands looking to reshore production or partner with U.S.-based adhesive manufacturers and liquid-fill experts. Our 100,000 sq ft. facility aligns with American time zones, communication styles, logistics, and manufacturing expectations.
Looking to explore how you can bring your manufacturing to America, strengthen your supply chain, reduce risk, accelerate time-to-market, and protect your IP?
Rely on us – made in America, by America, for America
FAQ
Reshoring brings production closer, speeding up development, improving quality control, and reducing supply-chain risks – especially important for regulated products like adhesives, hydrogels, and medical dressings. For example, if you’re looking for a hydrogel manufacturer, partnering within the U.S. ensures stronger oversight, faster turnaround, and better compliance
Labor costs may be higher, but companies often save overall by cutting shipping delays, import fees, quality issues, and long lead times. The total cost of ownership is usually lower.
Yes. Strukmyer offers R&D, Class 8 clean rooms, liquid compounding, filling, and end-to-end production under one roof, making it easy to scale without switching partners.
Medical devices, wound care, OTC products, personal care, cosmetics, and liquid-based products benefit most – speed, compliance, and reliability matter.
Better regulatory alignment, faster turnaround, stronger IP protection, tighter quality control, and fewer supply-chain disruptions – all leading to faster, more reliable product launches.
CITATIONS
NIST (National Institute of Standards and Technology), U.S. Department of Commerce (2025) How U.S. Manufacturers Can Take Advantage of Reshoring
International Trade Administration (2025) Reinvesting in the USA: A Case of Reshoring and Expanding in the United States
National Library of Medicine (2021) Regional factors enabling manufacturing reshoring strategies: A case study perspective